Inventor · disambiguated record
Jay Theroff
Also filed as: THEROFF JAY · THEROFF JAY P
17 granted patents·5 pending applications·129 citations·filing 2007–2024
94Inventor score
Files withUNIV TEXAS11CEPHALON INC4AHMED GULZAR2BOARD OF REGENTS UNIV OF TEXAS SYSTEM2BRESLIN HENRY J1
Top patents by PatentIndex Score
22 records- 0196US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0295US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0394US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0493US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0592US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 0692US7601716B2Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitorsCEPHALON INC·Filed 2007·Granted Oct 13, 2009·23 cites·19 claims
- 0789US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 0887US7919502B2Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitorsCEPHALON INC·Filed 2009·Granted Apr 5, 2011·9 cites·8 claims
- 0986US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1085US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 1183US9481692B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2015·Granted Nov 1, 2016·4 cites·10 claims
- 1282US10208059B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Feb 19, 2019·3 cites·6 claims
- 1381US8080561B2Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitorsDORSEY BRUCE D·Filed 2011·Granted Dec 20, 2011·8 cites·13 claims
- 1480US11001594B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2018·Granted May 11, 2021·1 cites·12 claims
- 1580US9018380B2Heterocyclic modulators of HIF activity for treatment of diseaseINST APPLIED CANCER SCIENCE THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CT·Filed 2013·Granted Apr 28, 2015·7 cites·10 claims
- 1673US8471005B2Pyrrolotriazines as ALK and JAK2 inhibitorsBRESLIN HENRY J·Filed 2011·Granted Jun 25, 2013·3 cites·10 claims
- 1750US9475766B2Substituted aromatic sulfur compounds and methods of their useCEPHALON INC·Filed 2013·Granted Oct 25, 2016·0 cites·43 claims
- 1849US11365189B2Heterocyclic inhibitors of tyrosine kinaseUNIV TEXAS·Filed 2020·Granted Jun 21, 2022·0 cites·30 claims
- 1946US2022194940A1Heterocyclic inhibitors of tyrosine kinaseUNIV TEXAS·Filed 2020·Application pending·0 cites
- 2043US2017029367A1Substituted Aromatic Sulfur Compounds and Methods of Their UseCEPHALON INC·Filed 2016·Application pending·0 cites
- 2140US2016060260A1Bromodomain inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 2235US2016002248A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay Theroff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →